« Home | Soldier faces threats from military after refusing... » | South Texans donate plasma to defend against anthr... » | Lawmakers concerned over slow pace of anthrax vacc... » | DON'T MISS the Montel Williams Show, Friday, Sep 7... » | Emergent BioSolutions Paid Lobbyist » | Judge Affirms Win for Plaintiffs in ‘Anthrax I’ Ca... » | Gulf War veteran believes illness related to anthr... » | PREMEDITATED MERGER - U.S. under U.N. law in healt... » | FDA licenses new vaccine against smallpox » | Inhaled anthrax vaccine promising in early studies... »

Emergent BioSolutions signs $448 mln contract


Sept 26 (Reuters) - Emergent BioSolutions Inc (EBS.N: Quote, Profile, Research) said it has signed a three-year contract worth $448 million with the U.S. health department, that includes delivery of anthrax vaccine, certain milestone payments and services.

The biopharmaceutical company said in a statement that it continues to expect full-year revenue growth of 10 percent to 15 percent, with a bias toward the upper end of the range, and positive net earnings. (Reporting by Deepti Chaudhary in Bangalore)